GlassScriptPhysician profile
Jude Farley Pierre
NPI 1750386108
$7,264.25
in general payments reported to CMS, 2019-2025
23 companies · $2,835 in 2025
The $2,835 reported for 2025 was more than what 93% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,621 · 2020: $253 · 2021: $290 · 2022: $445 · 2023: $438 · 2024: $382 · 2025: $2,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,979 · Travel and Lodging: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,979.08 |
| Travel and Lodging | $1,676.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $2,564.00 | 2019 | |
| Smith+Nephew, INC. | $2,527.56 | 2019-2025 | Pico, Collagenase Santyl, Grafix |
| Kerecis Limited | $506.74 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $420.96 | 2020-2023 | Krystexxa |
| Convatec INC. | $231.85 | 2023-2024 | |
| Surgenex LLC | $174.57 | 2025 | Surgraft, Ardeograft, Pellograft |
| Nevro Corp. | $144.54 | 2022-2024 | Senza |
| Solventum Corporation | $117.01 | 2024 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Triad Life Sciences INC. | $76.71 | 2021-2022 | |
| Averitas Pharma INC. | $75.02 | 2024-2025 | Qutenza |
| Acumed LLC | $74.28 | 2023 | Acumed |
| Organogenesis INC. | $69.57 | 2021-2024 | |
| Integra Lifesciences Corporation | $60.44 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $55.07 | 2022-2025 | Nuzyra |
| Orthofix Medical, INC. | $32.50 | 2022-2024 | Physio-Stim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeza LLC | $22.85 | 2023 | |
| Globus Medical, INC. | $22.14 | 2025 | Senza |
| Sanara Medtech INC. | $21.38 | 2022 | |
| Treace Medical Concepts, INC. | $15.72 | 2024 | |
| Mimedx Group, INC. | $14.91 | 2025 | |
| Orpyx Medical Technologies US INC. | $12.85 | 2023 | Orpyx Si |
| Kci USA, INC. | $12.26 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jude Farley Pierre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.